文献速递神经肿瘤

42例无IDH体细胞突变胶质母细胞瘤的基因组图谱:基于RNA测序数据的综合分析

Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
PubMed 文献 · J Neurooncol · 2024-04-23

研究对42例经临床常规切除、IDH1/IDH2为野生型的胶质母细胞瘤标本进行RNA测序,使用CLC Genomics Workbench分析。最常见遗传改变为TP53突变(28.6%)、EGFR剪接变异(16.7%)、EGFR突变(9.5%)和FGFR3融合(9.5%);8例(19%)检出新发遗传突变,12例(28.6%)未检出驱动基因突变,提示与PPP1R14A过表达相关。作者认为RNA测序是胶质母细胞瘤基因分型的有前景方法。

要点

  • 42例IDH野生型胶质母细胞瘤中TP53突变占28.6%,为最常见遗传改变。
  • EGFR剪接变异占16.7%,EGFR突变与FGFR3融合各占9.5%。
  • 12例(28.6%)未检出驱动基因突变,提示与PPP1R14A过表达相关。

核心结论

  • RNA测序可提供全面的基因表达信息且相对经济,是胶质母细胞瘤基因分型的有前景方法。
  • 转录因子SOX10和NKX6-2可能是胶质母细胞瘤的潜在标志物。

研究设计与样本

  • 研究分析42例经临床常规手术切除、IDH1和IDH2基因为野生型的胶质母细胞瘤标本。
  • 从冷冻标本提取RNA并测序,使用CLC Genomics Workbench进行遗传分析。

主要发现

  • 42例胶质母细胞瘤标本中最常见的遗传改变为TP53突变(28.6%)、EGFR剪接变异(16.7%)、EGFR突变(9.5%)和FGFR3融合(9.5%)。
  • 8例患者(19%)检出新的遗传突变。
  • 12例(28.6%)未检出驱动基因突变,提示与PPP1R14A过表达相关。
  • 研究提示转录因子SOX10和NKX6-2是胶质母细胞瘤的潜在标志物。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Glioblastoma is a malignant brain tumor with a poor prognosis. Genetic mutations associated with this disease are complex are not fully understood and require further elucidation for the development of new treatments. The purpose of this study was to comprehensively analyze genetic mutations in glioblastomas and evaluate the usefulness of RNA sequencing. PATIENTS AND METHODS: We analyzed 42 glioblastoma specimens that were resected in routine clinical practice and found wild-type variants of the IDH1 and IDH2 genes. RNA was extracted from frozen specimens and sequenced, and genetic analyses were performed using the CLC Genomics Workbench. RESULTS: The most common genetic alterations in the 42 glioblastoma specimens were TP53 mutation (28.6%), EGFR splicing variant (16.7%), EGFR mutation (9.5%), and FGFR3 fusion (9.5%). Novel genetic mutations were detected in 8 patients (19%). In 12 cases (28.6%), driver gene mutations were not detected, suggesting an association with PPP1R14A overexpression. Our findings suggest the transcription factors SOX10 and NKX6-2 are potential markers in glioblastoma. CONCLUSION: RNA sequencing is a promising approach for genotyping glioblastomas because it provides comprehensive information on gene expression and is relatively cost-effective.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Okamoto T, Mizuta R, Takahashi Y, et al. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data. J Neurooncol. 2024. PMID: 38653957. doi:10.1007/s11060-024-04628-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。